160 Participants NeededMy employer runs this trial

"What Is Important to Us" Communication for Neurological Impairment

JB
Overseen ByJori Bogetz, MD
Age: Any Age
Sex: Any
Trial Phase: Phase 2
Sponsor: Seattle Children's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The objective of this study is to conduct a pilot randomized controlled trial (RCT) of a photo-narrative communication intervention developed by our study team with patients/parents of children with severe neurological impairment (SNI) and their pediatric intensive care unit (PICU) clinicians to assess feasibility, acceptability, and early efficacy.

Who Is on the Research Team?

JB

Jori Bogetz, MD

Principal Investigator

Seattle Children's Hospital

Are You a Good Fit for This Trial?

Inclusion Criteria

I am a licensed clinician working in the pediatric ICU at Seattle Children's.
I am 3 months to 25 years old with severe neurological impairment and have been in the ICU before.

What Are the Treatments Tested in This Trial?

Interventions

  • What Is Important to Us Communication Intervention

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: "What Is Important to US" Communication InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Seattle Children's Hospital

Lead Sponsor

Trials
319
Recruited
5,232,000+